ONCOLYS BIOPHARMA INC.

Transcripts Oncolys BioPharma Inc.

Equities

4588

JP3202170001

Delayed Japan Exchange Other stock markets 08:40:21 2024-05-08 pm EDT			5-day change	1st Jan Change
692 ^JPY	-1.14%		-1.98%	+22.05%

Feb. 09	Oncolys BioPharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 07	Medigen Biotechnology Corp. Announces Signing of the Sales Cooperation Agreement for the New Drug OBP-301 in Japan	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oncolys BioPharma Inc. Provides Earning Guidance for the Year Ending December 31, 2022	22-08-05	CI
Oncolys BioPharma Inc. Provides Earning Guidance for the Year Ending December 31, 2022	22-05-13	CI
Oncolys Biopharma Inc. Provides Earning Guidance for the Year Ending December 31, 2022	22-02-10	CI
Oncolys BioPharma Inc. Provides Earnings Guidance for the Year Ending December 2021	21-11-05	CI
Oncolys Biopharma Inc. Provides Earnings Guidance for the Year Ending December 31, 2021	21-05-07	CI
Oncolys BioPharma Inc. Provides Earnings Guidance for the Year Ending December 31, 2021	21-02-12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW